Clinical trials in Brno-Sever – page 4

Clinical trials in Brno-Sever are strongly focused on digestive system diseases, especially Crohn’s disease and ulcerative colitis. These studies are mainly testing new ways to control inflammation, improve symptom relief, and support long-term disease management.

• Crohn’s disease
• Ulcerative colitis
• Endoscopic response and symptom control
• Evaluating new anti-inflammatory therapies

Many of these trials aim to improve remission rates and overall quality of life for people living with chronic bowel inflammation.

A major part of the research landscape covers immune system diseases and musculoskeletal diseases, including rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic lupus erythematosus. The trials are exploring better ways to reduce pain, stiffness, swelling, and long-term joint damage.

• Rheumatoid arthritis
• Psoriatic arthritis and axial spondyloarthritis
• Systemic lupus erythematosus and Sjögren’s disease
• Testing treatments that may improve disease control and safety

This area is especially active in the city, reflecting a broad effort to advance treatment options for chronic inflammatory conditions.

Trials in respiratory tract diseases and allergic conditions are examining asthma and seasonal allergic rhinitis. The main goal is to assess whether new therapies can better support breathing, reduce flare-ups, and ease allergy-related symptoms in children and adults.

• Asthma
• Seasonal allergic rhinitis and rhinoconjunctivitis
• Improving lung function and symptom relief
• Evaluating longer-term treatment benefit

These studies help expand options for people living with common but often disruptive respiratory and allergy problems.

Research in cardiovascular diseases and nutritional and metabolic diseases includes studies in high cardiovascular risk, atherosclerotic cardiovascular disease, hypertension, and obesity. The trials are designed to improve prevention and lower the risk of serious heart-related events.

• Atherosclerotic cardiovascular disease
• High cardiovascular risk and hypertension
• Obesity and related metabolic conditions
• Testing approaches that may reduce cardiovascular complications

Several studies also look at how better lipid control and weight-related care may support long-term heart health.

A broad oncology portfolio is active across neoplasms, with studies in acute myeloid leukemia, acute lymphoblastic leukemia, neuroblastoma, medulloblastoma, and other solid tumors. These trials are focused on improving outcomes for children, adolescents, and young adults with difficult-to-treat cancers.

• Acute myeloid leukemia and acute lymphoblastic leukemia
• Neuroblastoma, medulloblastoma, and solid tumors
• Pediatric and young adult cancer care
• Assessing new treatment combinations and response rates

In Brno-Sever, cancer research spans both common hematologic malignancies and rarer childhood tumors.

Clinical trials also cover skin and connective tissue diseases such as atopic dermatitis, psoriatic disease, and Netherton syndrome. The research is aimed at reducing inflammation, relieving itch and skin irritation, and improving daily comfort for patients.

• Atopic dermatitis
• Psoriatic arthritis and related inflammatory skin disease
• Netherton syndrome
• Evaluating new therapies for symptom improvement

These studies reflect a strong interest in targeted treatments for chronic and often visible skin conditions.

Trials in nervous system diseases include work on chronic migraine and muscular dystrophy, along with other conditions affecting movement and quality of life. The focus is on prevention, symptom reduction, and longer-term support for patients and families.

• Chronic migraine
• Duchenne muscular dystrophy
• Reducing attacks and improving daily functioning
• Studying longer-term treatment benefit and safety

These trials aim to address both frequent symptoms and the broader burden of chronic neurological disease.

Several studies focus on congenital, hereditary, and neonatal diseases, including achondroplasia, osteochondrodysplasia, and childhood-onset inflammatory disorders. This area also includes research in children with complex immune, metabolic, and developmental conditions.

• Achondroplasia
• Osteochondrodysplasia
• Children with inherited or early-onset disorders
• Improving care options for rare conditions

These trials are important for building evidence where treatment choices are often limited.

Research in hemic and lymphatic diseases includes hemophilia A and B, anemia associated with chronic kidney disease, and neutropenias. The studies are designed to improve blood-related outcomes, reduce complications, and support more stable disease control.

• Hemophilia A and B
• Anemia in chronic kidney disease
• Neutropenias
• Assessing treatment effectiveness and long-term safety

This area supports both inherited bleeding disorders and acquired blood count problems.

Although smaller in volume, trials in eye diseases and stomatognathic diseases contribute to a wider research portfolio. These studies may address vision-related concerns as well as conditions affecting the mouth and surrounding structures.

• Eye diseases
• Oral and stomatognathic conditions
• Improving diagnosis and treatment support
• Expanding care options across specialized fields

They add further breadth to the clinical trial activity seen across the city.

Some trials span several therapeutic areas and focus on rare or complex disorders such as juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, polymyalgia rheumatica, and myocardial and metabolic overlap conditions. These studies often aim to refine treatment choices where disease patterns are diverse and hard to manage.

• Juvenile idiopathic arthritis
• Polymyalgia rheumatica
• Complex inflammatory and multisystem disease
• Improving symptom control and treatment durability

This research adds an important rare-disease dimension to the trial landscape in Brno-Sever.